Atria Investments Inc Sells 427 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Atria Investments Inc cut its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 6.8% during the 4th quarter, Holdings Channel reports. The firm owned 5,842 shares of the company’s stock after selling 427 shares during the period. Atria Investments Inc’s holdings in U.S. Physical Therapy were worth $518,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. BNP Paribas Financial Markets increased its stake in U.S. Physical Therapy by 283.0% in the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock valued at $1,425,000 after acquiring an additional 12,445 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in U.S. Physical Therapy by 57.1% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock valued at $223,000 after acquiring an additional 956 shares during the last quarter. State Street Corp increased its stake in U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after acquiring an additional 99,244 shares during the last quarter. Stifel Financial Corp increased its stake in U.S. Physical Therapy by 12.1% in the third quarter. Stifel Financial Corp now owns 57,166 shares of the company’s stock valued at $4,838,000 after acquiring an additional 6,154 shares during the last quarter. Finally, Quest Partners LLC increased its stake in U.S. Physical Therapy by 2,368.2% in the third quarter. Quest Partners LLC now owns 8,614 shares of the company’s stock valued at $729,000 after acquiring an additional 8,265 shares during the last quarter.

Insider Buying and Selling at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of the company’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the transaction, the chief operating officer now owns 7,168 shares in the company, valued at approximately $588,564.48. This represents a 19.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.70% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on USPH. StockNews.com cut shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research note on Friday, February 28th. Bank of America upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and raised their target price for the company from $100.00 to $115.00 in a research report on Monday, December 16th. JMP Securities initiated coverage on shares of U.S. Physical Therapy in a research report on Monday, December 16th. They issued an “outperform” rating and a $113.00 target price on the stock. JPMorgan Chase & Co. raised their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Tuesday, December 3rd. Finally, Citizens Jmp upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $111.50.

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock opened at $76.68 on Friday. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63. The stock has a market cap of $1.16 billion, a price-to-earnings ratio of 81.57, a P/E/G ratio of 3.54 and a beta of 1.51. The company’s fifty day moving average is $86.17 and its 200 day moving average is $87.34.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. Sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be given a dividend of $0.45 per share. The ex-dividend date is Friday, March 14th. This represents a $1.80 dividend on an annualized basis and a yield of 2.35%. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s dividend payout ratio is 97.83%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.